Similarly to KRAS mutations, GNAS mutations did not vary according to the degree of dysplasia, suggesting that mutations in these genes occur early in IPMN carcinogenesis. The gene discussed is KRAS; the disease is pancreatic intraductal papillary-mucinous neoplasm.